Prodia Widyahusada Tbk PT
IDX:PRDA

Watchlist Manager
Prodia Widyahusada Tbk PT Logo
Prodia Widyahusada Tbk PT
IDX:PRDA
Watchlist
Price: 2 690 IDR -0.37% Market Closed
Market Cap: 2.5T IDR
Have any thoughts about
Prodia Widyahusada Tbk PT?
Write Note
Section:
 

Relative Value

The Relative Value of one PRDA stock under the Base Case scenario is 5 542.13 IDR. Compared to the current market price of 2 690 IDR, Prodia Widyahusada Tbk PT is Undervalued by 51%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PRDA Relative Value
Base Case
5 542.13 IDR
Undervaluation 51%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.1
P/S
P/S
Price to Sales
1.1
vs History
98
vs Industry
63
Median 3Y
2.3
Median 5Y
1.9
Industry
2.3
Forward
1.1
More Details
11.5
P/E
P/E
Price to Earnings
11.5
vs History
61
vs Industry
38
Median 3Y
13.5
Median 5Y
12.9
Industry
23.1
Forward
9.8
More Details
5.4
P/OCF
P/OCF
Price to OCF
5.4
vs History
96
vs Industry
39
Median 3Y
9.7
Median 5Y
9
Industry
14.2
More Details
21.4
P/FCFE
P/FCFE
Price to FCFE
21.4
vs History
41
vs Industry
13
Median 3Y
26
Median 5Y
15.3
Industry
20.1
More Details
1
P/B
P/B
Price to Book Value
1
vs History
93
vs Industry
59
Median 3Y
2.3
Median 5Y
2
Industry
2.2
More Details
0.8
EV/S
EV/S
Enterprise Value to Sales
0.8
vs History
85
vs Industry
73
Median 3Y
1.8
Median 5Y
1.5
Industry
2.4
Forward
0.8
More Details
1.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.4
vs History
88
vs Industry
77
Median 3Y
2.9
Median 5Y
2.5
Industry
5
More Details
7.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
7.3
vs History
57
vs Industry
42
Median 3Y
8.4
Median 5Y
8.1
Industry
12.7
Forward
3.8
More Details
7.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
7.3
vs History
57
vs Industry
44
Median 3Y
8.4
Median 5Y
8.1
Industry
17.1
Forward
5.6
More Details
3.9
EV/OCF
EV/OCF
Enterprise Value to OCF
3.9
vs History
84
vs Industry
47
Median 3Y
7.5
Median 5Y
6.7
Industry
14
More Details
5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
5
vs History
93
vs Industry
36
Median 3Y
10.9
Median 5Y
9
Industry
18
More Details
0.9
EV/IC
EV/IC
Enterprise Value to IC
0.9
vs History
93
vs Industry
57
Median 3Y
2.8
Median 5Y
2.4
Industry
1.9
More Details

Multiples Across Competitors

PRDA Competitors Multiples
Prodia Widyahusada Tbk PT Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
ID
Prodia Widyahusada Tbk PT
IDX:PRDA
2.5T IDR 1.1 11.5 7.3 7.3
US
Cigna Corp
NYSE:CI
78.7B USD 0.3 25.9 8.1 10.4
US
Cigna Group
XMUN:CGN
75.1B EUR 0.3 25.8 8 10.4
US
CVS Health Corp
NYSE:CVS
56.5B USD 0.2 11.3 9.6 9.6
DE
Fresenius Medical Care AG
XMUN:FME
25.8B EUR 1.3 48.6 11.2 25.8
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.8B EUR 0.9 -49.1 9.3 19
US
Laboratory Corporation of America Holdings
NYSE:LH
19.3B USD 1.5 44.4 13.2 20.5
US
Quest Diagnostics Inc
NYSE:DGX
17.1B USD 1.8 20.5 12.3 16.7
US
R1 RCM Inc
NASDAQ:RCM
16.9B USD 6.9 -275.9 36.7 94.9
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
12.9B EUR 0.7 24.3 7 16.3
US
DaVita Inc
NYSE:DVA
12.9B USD 1 15.5 8 11.2
P/E Multiple
Earnings Growth P/E to Growth
ID
Prodia Widyahusada Tbk PT
IDX:PRDA
Average P/E: 25.3
11.5
22%
0.5
US
Cigna Corp
NYSE:CI
25.9
96%
0.3
US
C
Cigna Group
XMUN:CGN
25.8
96%
0.3
US
CVS Health Corp
NYSE:CVS
11.3
8%
1.4
DE
Fresenius Medical Care AG
XMUN:FME
48.6
127%
0.4
DE
Fresenius SE & Co KGaA
XETRA:FRE
Negative Multiple: -49.1 N/A N/A
US
Laboratory Corporation of America Holdings
NYSE:LH
44.4
263%
0.2
US
Quest Diagnostics Inc
NYSE:DGX
20.5
41%
0.5
US
R1 RCM Inc
NASDAQ:RCM
Negative Multiple: -275.9
4 308%
N/A
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
24.3
127%
0.2
US
DaVita Inc
NYSE:DVA
15.5
61%
0.3

See Also

Summary
PRDA intrinsic value, competitors valuation, and company profile.
DCF Valuation
PRDA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PRDA stock valuation using valuation multiples.
Wall Street Estimates
PRDA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PRDA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.